Understanding the value of medicines is critical to decision-making about drug development, pricing, formulary management, clinical practice, and equitable access to treatment. Beyond the basic drug approval process at the FDA, a wide range of further drug evaluation is done by health economists, pharmacists, outcomes researchers, data analysts, and others, to inform how, and at what cost, drugs are made available to patients. This panel will begin by exploring some of the career paths taken by those working in this multi-disciplinary field. It will then discuss a variety of questions of current interest related to drug evaluation and coverage.
This event will be held in person on campus in Page Hall 010 and simulcasted on Zoom.